Practical Consequences Resulting from the Analysis of a 21-Multigene Array in the Interdisciplinary Conference of a Breast Cancer Center

Table 4

Details for cases with change of recommendation. ER/PR IRS: immunoreactive score for hormone receptors; RS: recurrence score; CT: adjuvant chemotherapy.

Case no.	Age	pT	pN	L	V	G	ER IRS	PR IRS	Ki67 %	RS	before Oncotype	after Oncotype
6	56	2	0 (0/2sn)	1	0	2	12	12	20	5	CT	No CT
10	49	1c (m)	1a (1/6sn)	0	0	2	12	12	15	8	No CT	CT
2	49	1c	1mi (2/16)	0	0	2	12	12	10	9	CT	No CT
16	39	2	0 (0/3sn)	0	0	2	12	9	10	25	CT	No CT
20	71	2	1a (1/12)	1	1	3	12	12	15	21	CT	No CT
45	50	1c	1a (1/10)	1	0	2	8	12	18	20	CT	No CT
12	69	1c	0 (0/5sn)	0	0	3	12	12	25	31	No CT	CT
38	64	2	0 (0/2sn)	0	0	3	12	0	50	37	No CT	CT